Vaccine News and Research

Latest Vaccine News and Research

UBC researchers find variation in kindergarten vaccination rates among local areas in Metro Vancouver

Children in some local health areas of Metro Vancouver have much lower vaccination rates than others, according to a recent University of British Columbia study.

16 Nov 2016

Research findings suggest efficacy of conventional flu vaccines can be improved

A team of engineers and scientists at The University of Texas at Austin is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved.

15 Nov 2016

NIH researchers identify antibody that potently neutralizes 98% of HIV strains

Scientists from the National Institutes of Health have identified an antibody from an HIV-infected person that potently neutralized 98 percent of HIV isolates tested, including 16 of 20 strains resistant to other antibodies of the same class.

15 Nov 2016

Study shows how Zika virus infection leads to production of smaller disease-causing RNAs

Researchers, led by scientists at the University of Colorado School of Medicine, have found basic molecular processes used by the Zika virus to "hijack" the cells that it infects and potentially how it makes molecules that are directly linked to disease.

11 Nov 2016

New report highlights need for innovations to combat pneumonia and diarrhea among children

A new report finds some progress in combatting pneumonia and diarrhea among young children in the nations most severely impacted by the two diseases, but they remain responsible for hundreds of thousands of preventable deaths around the world.

11 Nov 2016

Availability of flu vaccines, medications in school can keep children with asthma healthy

Kids need flu shots to prevent asthma flares, and medications available in school to keep 86 percent in class, according to two studies being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

11 Nov 2016

International consortium awarded $36.9 million grant to accelerate introduction of new typhoid vaccines

Typhoid fever, a bacterial infection that causes high fever and other disabling symptoms, remains a serious global problem in the developing world: it kills almost a quarter of a million people annually, and infects about 21 million.

10 Nov 2016

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

As the global spread of the Zika virus continues, efforts are underway to halt the disease's transmission.

10 Nov 2016

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

The administration of VRC01, a potent and broadly neutralizing HIV-specific antibody, is safe, is well-tolerated, generated high plasma concentrations and modestly delayed the return of HIV viral rebound in HIV-1 infected individuals after they stopped receiving antiretroviral therapy, according to a study published in the New England Journal of Medicine by researchers at the University of Alabama at Birmingham, the National Institutes of Health and the University of Pennsylvania Penn Center for AIDS Research.

10 Nov 2016

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

A study led by researchers at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research, Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV.

9 Nov 2016

Scientists show how key protein can be important driver of prostate cancer

Scientists at The Wistar Institute have demonstrated how a protein called TRAP1 - an important regulator of energy production in healthy and cancerous cells - is an important driver of prostate cancer and appears to be a valuable therapeutic target for the disease.

9 Nov 2016

Investigational treatment combination improves virologic control in SIV-infected monkeys

Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.

9 Nov 2016

Mosquito-borne diseases appear to be driven by infections in and around homes, research suggests

Outbreaks of the mosquito-borne disease chikungunya appear to be driven by infections centered in and around the home, with women significantly more likely to become ill, suggests new research from the Johns Hopkins Bloomberg School of Public Health, the Institut Pasteur in Paris and the International Centre for Diarrhoeal Disease Research, Bangladesh.

8 Nov 2016

Scientists turn iron-scavenging power against common UTI-causing bacteria

For most invading bacteria, the bladder is not a friendly place. But for those that have figured out how to scavenge iron from their hosts, it's a fine place to grow and reproduce.

7 Nov 2016

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine candidate called the Zika Purified Inactivated Virus (ZPIV) vaccine to generate an immune system response has begun at the Walter Reed Army Institute of Research Clinical Trial Center in Silver Spring, Maryland.

7 Nov 2016

Researchers discover antibody that can protect fetus from Zika virus in pregnant mice

The most devastating consequence of Zika virus infection is the development of microcephaly, or an abnormally small head, in babies who were infected in utero.

7 Nov 2016

Researchers discover set of immune proteins that facilitate long-lasting immunity against malaria

Houston Methodist researchers have discovered a set of immune proteins that facilitate long-lasting immunity against malaria.

7 Nov 2016

Vaccine-related rubella virus causes harm in some patients with primary immunodeficiency disorders

Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine.

7 Nov 2016

TB bacteria can be divided into generalists and specialists, study finds

Tuberculosis (TB) is a major global public health problem. Treatment often takes many months and till this day there is no effective vaccine. Various TB bacterial strains exist globally, with different geographical spread. Only the so-called Lineage 4 occurs on all continents.

4 Nov 2016

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson Cancer Research Center today announced the official opening of a first-of-its-kind clinic dedicated to providing innovative immunotherapies for cancer patients in clinical trials.

2 Nov 2016

Vaccine News and Research

Latest Vaccine News and Research

UBC researchers find variation in kindergarten vaccination rates among local areas in Metro Vancouver

Research findings suggest efficacy of conventional flu vaccines can be improved

NIH researchers identify antibody that potently neutralizes 98% of HIV strains

Study shows how Zika virus infection leads to production of smaller disease-causing RNAs

New report highlights need for innovations to combat pneumonia and diarrhea among children

Availability of flu vaccines, medications in school can keep children with asthma healthy

International consortium awarded $36.9 million grant to accelerate introduction of new typhoid vaccines

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Scientists show how key protein can be important driver of prostate cancer

Investigational treatment combination improves virologic control in SIV-infected monkeys

Mosquito-borne diseases appear to be driven by infections in and around homes, research suggests

Scientists turn iron-scavenging power against common UTI-causing bacteria

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

Researchers discover antibody that can protect fetus from Zika virus in pregnant mice

Researchers discover set of immune proteins that facilitate long-lasting immunity against malaria

Vaccine-related rubella virus causes harm in some patients with primary immunodeficiency disorders

TB bacteria can be divided into generalists and specialists, study finds

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in